Table 2.
A performance comparison between GRIm score and common hematological parameters.
| Parameters | level | Overall | Low GRIm score | High GRIm score | p |
|---|---|---|---|---|---|
| n | 313 | 81 | 232 | ||
| ALT | <21 | 142 (45.4) | 33 (40.7) | 109 (47.0) | 0.400 |
| ≥21 | 171 (54.6) | 48 (59.3) | 123 (53.0) | ||
| AST | <23 | 147 (47.0) | 36 (44.4) | 111 (47.8) | 0.690 |
| ≥23 | 166 (53.0) | 45 (55.6) | 121 (52.2) | ||
| AST/ALT | <1.44 | 267 (85.3) | 78 (96.3) | 189 (81.5) | 0.002 |
| ≥1.44 | 46 (14.7) | 3 (3.7) | 43 (18.5) | ||
| LDH | <170 | 156 (49.8) | 38 (46.9) | 118 (50.9) | 0.629 |
| ≥170 | 157 (50.2) | 43 (53.1) | 114 (49.1) | ||
| GGT | <14 | 142 (45.4) | 41 (50.6) | 101 (43.5) | 0.331 |
| ≥14 | 171 (54.6) | 40 (49.4) | 131 (56.5) | ||
| ALB | <45 | 145 (46.3) | 43 (53.1) | 102 (44.0) | 0.198 |
| ≥45 | 168 (53.7) | 38 (46.9) | 130 (56.0) | ||
| TBIL | <12.45 | 156 (49.8) | 44 (54.3) | 112 (48.3) | 0.419 |
| ≥12.45 | 157 (50.2) | 37 (45.7) | 120 (51.7) | ||
| DBIL | <3.9 | 155 (49.5) | 47 (58.0) | 108 (46.6) | 0.099 |
| ≥3.9 | 158 (50.5) | 34 (42.0) | 124 (53.4) | ||
| IBIL | <8.29 | 156 (49.8) | 43 (53.1) | 113 (48.7) | 0.583 |
| ≥8.29 | 157 (50.2) | 38 (46.9) | 119 (51.3) | ||
| TP | <74 | 132 (42.2) | 33 (40.7) | 99 (42.7) | 0.863 |
| ≥74 | 181 (57.8) | 48 (59.3) | 133 (57.3) | ||
| G | <29 | 137 (43.8) | 31 (38.3) | 106 (45.7) | 0.304 |
| ≥29 | 176 (56.2) | 50 (61.7) | 126 (54.3) | ||
| A/G | <1.5 | 104 (33.2) | 34 (42.0) | 70 (30.2) | 0.071 |
| ≥1.5 | 209 (66.8) | 47 (58.0) | 162 (69.8) | ||
| PAB | <267 | 156 (49.8) | 36 (44.4) | 120 (51.7) | 0.318 |
| ≥267 | 157 (50.2) | 45 (55.6) | 112 (48.3) | ||
| CA153 | <9.82 | 156 (49.8) | 44 (54.3) | 112 (48.3) | 0.419 |
| ≥9.82 | 157 (50.2) | 37 (45.7) | 120 (51.7) | ||
| CEA | <1.49 | 156 (49.8) | 35 (43.2) | 121 (52.2) | 0.209 |
| ≥1.49 | 157 (50.2) | 46 (56.8) | 111 (47.8) | ||
| D-D | <0.25 | 151 (48.2) | 41 (50.6) | 110 (47.4) | 0.713 |
| ≥0.25 | 162 (51.8) | 40 (49.4) | 122 (52.6) | ||
| FBG | <2.6 | 153 (48.9) | 48 (59.3) | 105 (45.3) | 0.041 |
| ≥2.6 | 160 (51.1) | 33 (40.7) | 127 (54.7) | ||
| INR | <0.97 | 139 (44.4) | 43 (53.1) | 96 (41.4) | 0.090 |
| ≥0.97 | 174 (55.6) | 38 (46.9) | 136 (58.6) | ||
| White blood cell | <5.45 | 156 (49.8) | 53 (65.4) | 103 (44.4) | 0.002 |
| ≥5.45 | 157 (50.2) | 28 (34.6) | 129 (55.6) | ||
| Neutrophil | <3.23 | 155 (49.5) | 68 (84.0) | 87 (37.5) | <0.001 |
| ≥3.23 | 158 (50.5) | 13 (16.0) | 145 (62.5) | ||
| Lymphocyte | <1.70 | 154 (49.2) | 19 (23.5) | 135 (58.2) | <0.001 |
| ≥1.70 | 159 (50.8) | 62 (76.5) | 97 (41.8) | ||
| NLR | Low | 105 (33.5) | 80 (98.8) | 25 (10.8) | <0.001 |
| High | 208 (66.5) | 1 (1.2) | 207 (89.2) | ||
| Monocyte | <0.35 | 151 (48.2) | 48 (59.3) | 103 (44.4) | 0.030 |
| ≥0.35 | 162 (51.8) | 33 (40.7) | 129 (55.6) | ||
| Platelet | <233 | 153 (48.9) | 37 (45.7) | 116 (50.0) | 0.589 |
| ≥233 | 160 (51.1) | 44 (54.3) | 116 (50.0) |
Abbreviation: GRIm score: Gustave Roussy Immune score; ALT: alanine aminotransferase; AST: aspartate aminotransferase; LDH: lactate dehydrogenase; GGT: γ-glutamyl transpeptidase; ALB: albumin; TBIL: total bilirubin; DBIL: direct bilirubin; IBIL: indirect bilirubin; TP: total protein; G: globularproteins; PAB: prealbumin; CA153: cancer antigen 153; CEA: carcinoembryonic antigen; D-D: D-Dimer; FBG: fibrinogen; INR: international normalized ratio; NLR: neutrophil to lymphocyte ratio.